| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/15/2006 | WO2006027310A3 Modulation of plant cell number |
| 06/15/2006 | WO2006026537A3 Site-specific recombination systems for use in eukaryotic cells |
| 06/15/2006 | WO2006025074A3 Twodimensional strandness- and length-dependent separation of nucleic acid fragments |
| 06/15/2006 | WO2006024880A9 Methods and compositions to inhibit p2x7 receptor expression |
| 06/15/2006 | WO2006015389A3 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 06/15/2006 | WO2006014271A3 Generation of plants with altered oil content |
| 06/15/2006 | WO2006013572A3 Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
| 06/15/2006 | WO2006012365A3 Protease inhibitor |
| 06/15/2006 | WO2006008090A3 Method for purifying and isolating nucleic acids using cationic detergents |
| 06/15/2006 | WO2006005054A3 System and methods for the management and treatment of vascular graft disease |
| 06/15/2006 | WO2006002387A3 Gdf3 propeptides and related methods |
| 06/15/2006 | WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 06/15/2006 | WO2005118824A9 Methods and compositions for the inhibition of gene expression |
| 06/15/2006 | WO2005118824A2 Methods and compositions for the inhibition of gene expression |
| 06/15/2006 | WO2005117993A3 Method of using adenoviral vectors with improved safety and efficacy for the treatment of cancer |
| 06/15/2006 | WO2005116070A3 Reporter system for detecting signal pathway activation in multiple cell types |
| 06/15/2006 | WO2005112621A3 A murine model of hiv-1 infection |
| 06/15/2006 | WO2005107437A3 Novel herbicide resistance genes |
| 06/15/2006 | WO2005100590A3 Cell display libraries |
| 06/15/2006 | WO2005072272A3 Compositions and methods for generating short double-stranded rna using mutated rnase iii |
| 06/15/2006 | WO2005047516A3 Plant transcriptional regulators |
| 06/15/2006 | WO2005005599A3 Modulation of c-reactive protein expression |
| 06/15/2006 | WO2004019890A3 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 06/15/2006 | WO2004015083A3 Compositions and uses of motor protein-binding moieties |
| 06/15/2006 | WO2003092363A3 Transgenic high tryptophan plants |
| 06/15/2006 | US20060130189 Inbred corn line PHCEG |
| 06/15/2006 | US20060130187 Soybean variety XB11L06 |
| 06/15/2006 | US20060130185 Plant transformation and selection |
| 06/15/2006 | US20060130184 Seed-preferred regulatory elements |
| 06/15/2006 | US20060130182 Transgenic expression of nucleic acid sequences in starch-comprising tissues of plants, preferably in fruits, roots, seeds or tubers, wherein the nucleic acid sequence is expressed under the control of a promoter of a starch synthase 3 |
| 06/15/2006 | US20060130181 Plant cells and plants which synthesize a starch with an increased final viscosity |
| 06/15/2006 | US20060130180 Method of enhancing expression of exogenous polynucleotide sequences in plants |
| 06/15/2006 | US20060130179 Lambda integrase mediated recombination in plants |
| 06/15/2006 | US20060130178 the transcription regulating nucleotide sequence has meristem-preferential or meristem-specific expression activity; for expression of selected transgenes in economically important plants |
| 06/15/2006 | US20060130177 Such as blast fungus and/or leaf-blight bacteria by transforming plants with DNA encoding protein that induces hypersensitive reaction-like lesion mimic; progeny, seeds, plants |
| 06/15/2006 | US20060130176 MicroRNAs |
| 06/15/2006 | US20060130175 Polynucleotide of given sequence; expression cassettes linked to gene encoding toxins or use as markers; control moths |
| 06/15/2006 | US20060130174 Transposon and transposase genes of rice, transposase, transformant and method of use |
| 06/15/2006 | US20060130173 Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals |
| 06/15/2006 | US20060130172 Gene encoding resistance to acetolactate synthase-inhibiting herbicides |
| 06/15/2006 | US20060130171 Organogenic transformation and regeneration |
| 06/15/2006 | US20060130170 Avian transgenesis using a chicken ovalbumin gene region |
| 06/15/2006 | US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls. |
| 06/15/2006 | US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells |
| 06/15/2006 | US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/15/2006 | US20060128942 Method for protein isolation in anoxic conditions |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128650 Allele-specific RNA interference |
| 06/15/2006 | US20060128649 Aptamer-mediated regulation of gene expression |
| 06/15/2006 | US20060128648 Preparing a suppression effector and replacement nucleic acid that have modifications in one or more third base (wobble) positions so that replacement nucleic acids still code for the wild type or equivalent amino acids |
| 06/15/2006 | US20060128647 Novel oligonucleotides and treating cardiac disorders by using the same |
| 06/15/2006 | US20060128646 Antisense design |
| 06/15/2006 | US20060128645 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 06/15/2006 | US20060128644 Use of mob-5 in pain |
| 06/15/2006 | US20060128617 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 06/15/2006 | US20060128615 Ghrh analogues |
| 06/15/2006 | US20060128030 substrate for bioassay in which reaction region serving as a field of mutual reaction between probe material and sample material is formed; bioassaying apparatus and method are adapted for detecting fluorescence produced from fluorescence marking agent existing in the reaction region |
| 06/15/2006 | US20060128021 Unusual retrotransposon from the yeast Candida albicans |
| 06/15/2006 | US20060128020 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 06/15/2006 | US20060128019 Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase |
| 06/15/2006 | US20060128018 Directed genetic modifications of human stem cells |
| 06/15/2006 | US20060128017 Process for the production of an active molecule vector used to diffuse active substances and vector thus obtained |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060128000 Enone reductase gene and microbial production of levodione |
| 06/15/2006 | US20060127997 Process for the preparation of compounds with enhanced optical purity |
| 06/15/2006 | US20060127994 Aldehyde dehydrogenase gene |
| 06/15/2006 | US20060127993 Thiamin production by fermentation |
| 06/15/2006 | US20060127990 4'-thionucleotide |
| 06/15/2006 | US20060127989 Antigenic fragment of human T-lymphotropic virus |
| 06/15/2006 | US20060127988 Using site directed mutagenesis of regulatory/enhancer sequences to improve efficiency of vector transformation and expression |
| 06/15/2006 | US20060127986 Genetically engineered Recombinant actinomycete cells for use as tool for the generation of heterologous proteins; contains nucleic acid molecules which comprise at least two modules that encode a modular polyketide synthase |
| 06/15/2006 | US20060127984 Modified Vaccinia virus Ankara for the vaccination of neonates |
| 06/15/2006 | US20060127982 Development of an asporogenic bacillus licheniformis and production of keratinase therefrom |
| 06/15/2006 | US20060127980 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 06/15/2006 | US20060127978 Nucleic acid recombination method, host cell and expression vector |
| 06/15/2006 | US20060127976 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 06/15/2006 | US20060127973 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof |
| 06/15/2006 | US20060127972 In vivo production of cephalosporins |
| 06/15/2006 | US20060127959 Antibodies that bind M. tuberculosis polypeptides |
| 06/15/2006 | US20060127940 Dual resonance energy transfer nucleic acid probes |
| 06/15/2006 | US20060127937 Novel Survivin interacting protein TPR1 |
| 06/15/2006 | US20060127936 Compositions and methods for labeling of nucleic acid molecules |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127925 Comprising surface and conjugate where conjugate is immobilized on surface only through an associative interaction between first and second polymers, and wherein stimulus is a temperature-sensitive stimulus and first and second polymers are selected from poly(N-isopropylacrylamide and copolymer thereof |
| 06/15/2006 | US20060127923 Internal ribosomal entry site mediated gene expression |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127907 Method of detecting gene mutation |
| 06/15/2006 | US20060127905 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase |
| 06/15/2006 | US20060127904 Hybridization sensing part, sensor chip, and hybridization method |
| 06/15/2006 | US20060127900 Method for detecting increased susceptibility to tumors |
| 06/15/2006 | US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 06/15/2006 | US20060127895 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127893 Modification of human variable domains |
| 06/15/2006 | US20060127892 Quantitative diagnostic analysis of hypertonia |
| 06/15/2006 | US20060127891 RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA) |
| 06/15/2006 | US20060127877 Fluorescent protein |